Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. - Archive ouverte HAL Access content directly
Journal Articles Journal of Virology Year : 1998

Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

(1) , (1) , (2) , (3) , (1)
1
2
3

Abstract

Following cell surface receptor binding and membrane fusion, human immunodeficiency virus (HIV) virion cores are released in the cytoplasm. Incoming viral proteins represent potential targets for cytosolic proteases. We show that treatment of target cells with the proteasome inhibitors MG132 and lactacystin increased the efficiency of HIV infection. Proteasome inhibitors were active at the early steps of the viral cycle. Incoming p24Gag proteins accumulated in the cytosol, and larger amounts of proviral DNA were synthesized. In vitro, purified 20S proteasome degraded HIV virion components. Thus, degradation of incoming viral proteins by the proteasome represents an early intracellular defense against infection.

Dates and versions

pasteur-01372751 , version 1 (27-09-2016)

Identifiers

Cite

O Schwartz, V Maréchal, B Friguet, F Arenzana-Seisdedos, J M Heard. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.. Journal of Virology, 1998, 72 (5), pp.3845-50. ⟨pasteur-01372751⟩

Collections

PASTEUR CNRS
18 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More